#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	1884	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2471	223.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1632	1632	C	287	C	254	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3130	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4368	213.2	0	.	n	.	0	T695C	SNP	695	695	T	1613	1613	C	228	C,T	202,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3130	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4368	213.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	2255	2255	A	277	A	247	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3130	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4368	213.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2889	2889	C	283	C,A	249,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3130	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4368	213.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3515	3515	T	282	T	254	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	3130	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4368	213.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2963	2963	A	271	A	246	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	456	folP	852	852	100.0	folP.l15.c4.ctg.1	1979	68.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1217	1219	AGC	94;94;93	A;G;C	86;86;82	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	840	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3927	63.7	1	SNP	p	S91F	0	.	.	271	273	TCC	801	803	TCC	83;83;83	T;C;C	73;73;67	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	840	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3927	63.7	1	SNP	p	D95G	0	.	.	283	285	GAC	813	815	GAC	87;87;88	G;A,C;C	76;72,1;76	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	840	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3927	63.7	1	SNP	p	D95N	0	.	.	283	285	GAC	813	815	GAC	87;87;88	G;A,C;C	76;72,1;76	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	378	mtrR	633	633	99.84	mtrR.l6.c4.ctg.1	1849	61.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	272	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1530	52.7	0	.	n	.	0	C187G	SNP	187	187	C	787	787	G	100	G,T	90,1	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	916	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3363	81.0	1	SNP	p	D86N	0	.	.	256	258	GAC	803	805	GAC	93;92;92	G;A;C	80;77;81	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	916	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3363	81.0	1	SNP	p	S87R	0	.	.	259	261	AGT	806	808	AGT	92;90;90	A;G;T	75;79;74	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	916	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3363	81.0	1	SNP	p	S87I	0	.	.	259	261	AGT	806	808	AGT	92;90;90	A;G;T	75;79;74	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	916	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3363	81.0	1	SNP	p	S87W	0	.	.	259	261	AGT	806	808	AGT	92;90;90	A;G;T	75;79;74	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	916	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3363	81.0	1	SNP	p	S88P	0	.	.	262	264	TCC	809	811	TCC	89;90;92	T;C;C	74;78;81	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	820	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3303	74.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1916	1918	GGC	102;103;104	G;G,A;C	93;90,1;90	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2842	61.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1477	1479	GCA	91;90;89	G;C;A	85;83;86	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2842	61.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1480	1482	ATC	88;88;89	A;T;C	81;82;82	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2842	61.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1492	1494	GTG	92;92;94	G,A,T;T;G	82,1,1;84;87	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2842	61.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1492	1494	GTG	92;92;94	G,A,T;T;G	82,1,1;84;87	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2842	61.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1996	1998	ACC	62;62;62	A;C;C	54;54;57	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2842	61.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2050	2052	GCG	64;64;63	G;C;G	52;47;51	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2842	61.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2050	2052	GCG	64;64;63	G;C;G	52;47;51	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2842	61.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2173	2175	GGC	58;57;57	G;G;C	54;52;51	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2842	61.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2182	2184	GGC	57;57;57	G;G;C	48;54;52	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	586	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2842	61.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2200	2202	CCG	63;63;62	C,G;C;G,A	54,1;55;49,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	654	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3548	55.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1806	1808	CTG	60;61;62	C;T;G	50;51;52	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	356	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2335	45.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	734	734	C	64	C	59	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	179	90.71	porB1a.l6.c4.ctg.1	1323	15.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1169	1171	AAT	5;5;5	A;A;T	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	179	90.71	porB1a.l6.c4.ctg.1	1323	15.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1172	1174	AAT	4;4;4	A;A;T	3;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	179	90.71	porB1a.l6.c4.ctg.1	1323	15.4	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1184	1186	GTT	4;4;4	G;T;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	179	90.71	porB1a.l6.c4.ctg.1	1323	15.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1196	1198	GCA	4;4;4	G;C;A	3;3;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	179	90.71	porB1a.l6.c4.ctg.1	1323	15.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1219	1221	GTA	4;4;4	G;T;A	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	72	porB1a	984	179	90.71	porB1a.l6.c4.ctg.1	1323	15.4	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1228	1228	A	4	A	4	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	G38E	NONSYN	112	114	GGA	621	623	GAA	88;90;91	G;A;A	76;77;76	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	S46G	NONSYN	136	138	AGC	645	647	GGC	86;86;85	G;G;C	72;73;73	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	E48G	NONSYN	142	144	GAA	651	653	GGA	86;86;86	G;G;A	73;73;73	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	T87A	NONSYN	259	261	ACT	768	770	GCT	81;81;81	G,A;C;T,G	70,1;73;72,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	T89S	NONSYN	265	267	ACC	774	776	AGC	80;80;80	A,G;G;C	70,1;74;73	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	.	MULTIPLE	358	359	AA	866	867	CG	77;77	C;G	66;66	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	.	MULTIPLE	361	362	GA	869	871	CAG	77;76;76	C;A;G,C	66;67;65,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	N122K	NONSYN	364	366	AAC	873	875	AAA	75;74;74	A;A;A	66;65;66	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	K143E	NONSYN	427	429	AAA	936	938	GAA	79;79;80	G;A,G;A	71;72,1;72	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	V151A	NONSYN	451	453	GTA	960	962	GCA	79;80;80	G,T,A;C;A,T	67,1,1;68;68,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1068	1070	CGA	68;68;68	C;G;A	62;62;63	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1152	1154	ACT	72;72;72	A,G,T;C,T;T	61,2,1;63,1;65	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	Y216H	NONSYN	646	648	TAT	1155	1157	CAT	72;71;71	C,T;A;T	65,1;64;65	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1161	1163	ATG	71;72;73	A,G;T;G,C	64,1;66;64,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	.	MULTIPLE	766	767	AC	1275	1277	GCA	66;66;64	G;C,T;A,G	58;55,1;58,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	W257R	NONSYN	769	771	TGG	1279	1281	CGG	64;64;63	C;G;G,T	56;58;55,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	0	.	p	.	0	S258fs	FSHIFT	772	772	A	1282	1282	A	62	A	50	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	1	SNP	p	G120K	1	.	.	358	360	AAG	866	868	CGG	77;77;77	C;G;G,A	66;66;65,1	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	1	SNP	p	A121D	1	.	.	361	363	GAC	869	872	CGC	77;76;76	C;G,C;C	66;65,1;66	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	378	porB1b	1047	1047	96.57	porB1b.l15.c4.ctg.1	2051	54.2	1	SNP	p	D121N	0	.	.	361	363	GAC	869	872	CGC	77;76;76	C;G,C;C	66;65,1;66	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1036	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5499	55.8	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2253	2255	AAT	66;66;66	A;A;T	61;60;59	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	116	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1548	22.3	1	SNP	p	V57M	1	.	.	169	171	ATG	812	814	ATG	46;46;45	A;T;G	40;41;40	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
